NEW YORK ( TheStreet) -- Regeneron Pharmaceuticals (Nasdaq: REGN) hit a new 52-week high Tuesday as it is currently trading at $124.56, above its previous 52-week high of $124.50 with 183,015 shares traded as of 11:15 a.m. ET. Average volume has been 1.1 million shares over the past 30 days. Regeneron has a market cap of $11.12 billion and is part of the health care sector and drugs industry. Shares are up 121.1% year to date as of the close of trading on Monday. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter